Perspective Therapeutics, Inc. (CATX) Stock Overview
Explore Perspective Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Perspective Therapeutics, Inc. (CATX)
Key Financials
Key Financials
Market Cap
352.4M
P/E Ratio
-2.21
EPS (TTM)
$-1.41
ROE
-0.42%
CATX Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of Perspective Therapeutics, Inc. (AMEX: CATX) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Perspective Therapeutics, Inc.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CATX on the AMEX shows an RSI of 51.17, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the AMEX listing.
Key metrics behind Perspective Therapeutics, Inc.'s AMEX-traded stock include a P/E ratio of -2.21 and a market capitalization of 352.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CATX on the AMEX.